1. Home
  2. EYEN vs ELTX Comparison

EYEN vs ELTX Comparison

Compare EYEN & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYEN
  • ELTX
  • Stock Information
  • Founded
  • EYEN 2014
  • ELTX 2011
  • Country
  • EYEN United States
  • ELTX United States
  • Employees
  • EYEN N/A
  • ELTX N/A
  • Industry
  • EYEN Biotechnology: Pharmaceutical Preparations
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EYEN Health Care
  • ELTX Health Care
  • Exchange
  • EYEN Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • EYEN 38.2M
  • ELTX 49.7M
  • IPO Year
  • EYEN 2018
  • ELTX 2021
  • Fundamental
  • Price
  • EYEN $0.55
  • ELTX $4.16
  • Analyst Decision
  • EYEN Strong Buy
  • ELTX Buy
  • Analyst Count
  • EYEN 2
  • ELTX 2
  • Target Price
  • EYEN $12.00
  • ELTX $10.00
  • AVG Volume (30 Days)
  • EYEN 879.0K
  • ELTX 16.1K
  • Earning Date
  • EYEN 11-11-2024
  • ELTX 11-07-2024
  • Dividend Yield
  • EYEN N/A
  • ELTX N/A
  • EPS Growth
  • EYEN N/A
  • ELTX N/A
  • EPS
  • EYEN N/A
  • ELTX N/A
  • Revenue
  • EYEN $31,405.00
  • ELTX N/A
  • Revenue This Year
  • EYEN $50,309.30
  • ELTX N/A
  • Revenue Next Year
  • EYEN $421.63
  • ELTX N/A
  • P/E Ratio
  • EYEN N/A
  • ELTX N/A
  • Revenue Growth
  • EYEN N/A
  • ELTX N/A
  • 52 Week Low
  • EYEN $0.37
  • ELTX $2.96
  • 52 Week High
  • EYEN $2.57
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • EYEN 52.60
  • ELTX 40.82
  • Support Level
  • EYEN $0.52
  • ELTX $4.05
  • Resistance Level
  • EYEN $0.59
  • ELTX $4.89
  • Average True Range (ATR)
  • EYEN 0.05
  • ELTX 0.28
  • MACD
  • EYEN 0.01
  • ELTX -0.06
  • Stochastic Oscillator
  • EYEN 66.45
  • ELTX 27.37

About EYEN Eyenovia Inc.

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: